glp-1 summit Home Havas Health Brings GLP-1 Consultancy

New research clearly shows that non-diabetic people face high gastroparesis risks when they use GLP-1 agonists

If gastrointestinal symptoms significantly impair quality of life or prevent medication adherence despite conservative management, healthcare providers may consider dose adjustment, alternative agents with potentially different side effect profiles, or referral to a gastroenterologist for specialized evaluation

These medications work by neutralizing stomach acid to help relieve symptoms

Is the timeline different for Ozempic vs

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) promote physiologic glucose-dependent insulin release